🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Prof Oliver Karanfilski

Jul 2, 2026 | ECLLA Policy Roundtabe, News

European CLL Association – ECLLA is proud to work alongside Prof Oliver Karanfilski, Professor of Hematology and Internal Medicine and Consultant Hematologist from Macedonia, whose expertise brings an essential perspective to our Medical Advisory Board. At the...

ECLLA Co-Founder Michael Rynne Attends the Cancer Patients Europe Annual Meeting 2026

Jun 26, 2026 | News

ECLLA Co-founder Michael Rynne attended the Cancer Patients Europe (CPE) Annual Meeting 2026, held in Brussels from 24–26 June under the theme “Protecting and Improving Europe’s Cancer Care Model in a Changing World.” The three-day meeting brought...

🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Dr Brian Koffman

Jun 23, 2026 | ECLLA Policy Roundtabe, News

ECLLA is deeply grateful to Dr Brian Koffman, MDCM (retired) MS Ed, Co-Founder and Chief Medical Officer Emeritus, CLL Society Inc., and member of European CLL Association – ECLLA Medical Advisory Board, for bringing both professional expertise and lived...

ECLLA Team Attends EHA 2026 Congress in Stockholm 11–14, 2026

Jun 15, 2026 | News

The ECLLA team proudly participated in the 31st Congress of the European Hematology Association (EHA 2026), held from June 11–14, 2026, in Stockholm, Sweden. As one of the world’s premier hematology events, EHA brings together leading experts, researchers,...

📍 Live from Stockholm! Breakfast panel discussion on “Time-Limited Treatment in CLL: The Holistic Impact of Treatment-Free Periods for the Patient, the Care Partner and the Wider CLL Community”

Jun 11, 2026 | EHA Panel 2026, News

Today, ECLLA is bringing together clinicians, patient advocates, care partners, nurse, and policy expert from across Europe for our multi-stakeholder panel discussion: “Time Off Treatment in CLL: Clinical Control and Patient Priorities in Fixed-Duration Treatment”...